Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Business Update — Neutral
RYTM GlobeNewsWire — February 26, 2025-- Fourth quarter 2024 net revenue from global sales of IMCIVREE® (setmelanotide) of $41.8 million -- -- On track to report topline data from global Phase 3 trial evaluating setmelanotide in acquired hypothalamic obesity in the second quarter of 2025 -- -- Completed enrollment in the Phase 2 trial of oral MC4R agonist bivamelagon in acquired hypothalamic obesity -- -- FDA approved expanded label for IMCIVREE to include children as young as 2 years old -- -- Raised approximately $75 million in gross proceeds under ATM equity offering program; Cash runway extended into 2027 -- -- Management to host conference …

Boundless Bio to Participate in the Leerink Global Healthcare Conference — Neutral
BOLD GlobeNewsWire — February 26, 2025SAN DIEGO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in Leerink's Global Healthcare Conference. A fireside chat session is scheduled for Wednesday, March 12, 2025, in Miami, FL, at 11:20 a.m.

REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! — Neutral
REGN Accesswire — February 26, 2025NEW YORK CITY, NY / ACCESS Newswire / February 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. ("Regeneron" or "the Company") (NASDAQ:REGN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Regeneron securities between November 2, 2023 and October 30, 2024, both dates inclusive (the "Class Period").

TIXT Stockholders Have Opportunity to Lead TELUS International (Cda) Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! — Neutral
TIXT Accesswire — February 26, 2025NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TELUS International (Cda) Inc. ("TELUS" or "the Company") (NYSE:TIXT) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired TELUS securities between February 16, 2023 and August 1, 2024, both dates inclusive (the "Class Period").

GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of GSK plc to Contact the Firm Today! — Neutral
GSK Accesswire — February 26, 2025NEW YORK CITY, NY / ACCESS Newswire / February 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against GSK plc ("GSK" or "the Company") (NYSE:GSK) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GSK American Depositary Receipts ("ADRs") between February 5, 2020 and August 14, 2022, both dates inclusive (the "Class Period").

FBTC: Record Outflow Could Signal A Capitulation Bottom — Negative
FBTC Seeking Alpha — February 26, 2025Bitcoin has entered bear market territory and FBTC saw record outflows. FBTC's decline is driven by profit-taking, broader market risk-off sentiment, and memecoin collapses, not specific negative news. Despite headlines, the overall newsflow is positive, and recent capitulation may indicate a market bottom.

Lowe's stock jumps as same-store sales rise for first time in 2 years — Positive
LOW Market Watch — February 26, 2025Lowe's reported quarterly results that beat expectations but gave a downbeat full-year outlook a day after rival Home Depot did the same.

Q32 Bio to Participate in Upcoming March Investor Conferences — Neutral
QTTB PRNewsWire — February 26, 2025WALTHAM, Mass. , Feb. 26, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced that management will participate in two upcoming investor conferences in March: TD Cowen 45th Annual Health Care Conference Date: Wednesday, March 5, 2025 Presentation Time: 11:50 a.m.

Steve Madden Announces Fourth Quarter and Full Year 2024 Results — Neutral
SHOO GlobeNewsWire — February 26, 2025~ Provides 2025 Outlook ~ LONG ISLAND CITY, N.Y., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Steve Madden (Nasdaq: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided its 2025 outlook.

Stantec Inc. (NYSE:STN ) Q4 2024 Earnings Conference Call February 25, 2025 4:30 PM ET Company Participants Gord Johnston - President and Chief Executive Officer Vito Culmone - Executive Vice President and Chief Financial Officer Conference Call Participants Sabahat Khan - RBC Krista Friesen - CIBC Chris Murray - ATB Capital Markets Frederic Bastien - Raymond James Yuri Lynk - Canaccord Genuity Michael Tupholme - TD Cowen Benoit Poirier - Desjardins Devin Dodge - BMO Capital Markets Maxim Sytchev - NBF Jonathan Goldman - Scotiabank Operator Welcome to Stantec's Fourth Quarter and Full Year 2024 Results Webcast and Conference Call. …

Amazon Banking on Robotics Savings Amid Increased AI Spending — Neutral
AMZN PYMNTS — February 26, 2025Amazon is aiming to derive savings from its robotics investment as it ups AI spending. As the Financial Times (FT) reported Wednesday (Feb.

Palantir and the Nasdaq are both on a losing streak.

The ODP Corporation Announces Fourth Quarter and Full Year 2024 Results — Neutral
ODP Business Wire — February 26, 2025BOCA RATON, Fla.--(BUSINESS WIRE)--The ODP Corporation Announces Fourth Quarter and Full Year 2024 Results.

Valens Semiconductor Reports Fourth Quarter and Full Year 2024 Results — Neutral
VLN PRNewsWire — February 26, 2025Key Financial Highlights: Q4 revenues: $16.7 million, exceeding the top end of our guidance and marking the fourth consecutive quarter of revenue growth. Q4 gross margin: 60.4% GAAP; 64.5% non-GAAP.

Wallbox Announces Fourth Quarter & Full Year 2024 Financial Results — Neutral
WBX Business Wire — February 26, 2025BARCELONA, Spain--(BUSINESS WIRE)--Wallbox N.V. (NYSE:WBX), a leading provider of electric vehicle (“EV”) charging and energy management solutions worldwide, today announced its financial results for the fourth quarter and full year ended December 31, 2024 and provided a business update. Fourth Quarter 2024 Highlights and Business Update: Generated revenue of €37.4 million, representing growth of 8% compared to the last quarter North American market maintained strong momentum, achieving 64% yea.

CLEAR Announces Leadership Transition: Michael Barkin Joins as President, Jen Hsu Named CFO, and Ken Cornick to Step Down — Neutral
YOU GlobeNewsWire — February 26, 2025NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity platform, today announced that Ken Cornick, Co-Founder, President, and Chief Financial Officer, is stepping down from his executive positions and will transition to an advisory role. Cornick helped bring CLEAR's vision of a global secure identity platform to life – starting in travel and expanding into enterprises to make experiences safer and easier both physically and digitally. In 2010, CLEAR started with just 190,000 Members and today has over 30 million Members on our secure identity platform.

Enovis Announces Fourth Quarter and Full Year 2024 Results — Neutral
ENOV GlobeNewsWire — February 26, 2025Wilmington, DE, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (“Enovis” or “the Company”) (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2024. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET.

Sequans to Participate in 37th Annual Roth Conference on March 18, 2025 — Neutral
SQNS Newsfile Corp — February 26, 2025Paris, France--(Newsfile Corp. - February 26, 2025) - Sequans Communications S.A. (NYSE: SQNS), a leading provider of 4G and 5G semiconductors and modules for the Internet of Things, today announced that Georges Karam, President and CEO, and Deborah Choate, CFO, will participate in the 37th Annual Roth Conference being held March 16-18, 2025, at The Laguna Cliffs Marriott in Laguna Beach, California.

Escalade Reports Fourth Quarter and Full Year 2024 Results — Neutral
ESCA PRNewsWire — February 26, 2025EVANSVILLE, Ind. , Feb. 26, 2025 /PRNewswire/ -- Escalade, Inc. (Nasdaq: ESCA, or the "Company"), a leading manufacturer and distributor of sporting goods and indoor/outdoor recreational equipment, today announced results for the fourth quarter and full year 2024.
